Fulminant Epstein-Barr virus (EBV) hepatitis in a young immunocompetent subject

被引：16

作者：

Ader, F.

Chatellier, D.

Le Berre, R.

Morand, P.

Fourrier, F.

机构：

[1] CH Tourcoing, Hop Gustave Dron, Serv Univ Reanimat Med & Malad Infect, F-59208 Tourcoing, France

[2] CHU Poiters, Serv Reanimat Med, F-86021 Poitiers, France

[3] CHU Cavale Blanche, Serv Malad Infect, F-29609 Brest, France

[4] CHU Grenoble, Serv Virol, F-38043 Grenoble, France

[5] CHU Lille, Hop Roger Salengro, Serv Reanimat Polyvalente, F-59031 Lille, France

来源：

MEDECINE ET MALADIES INFECTIEUSES | 2006年 / 36卷 / 07期

关键词：

Epstein-Barr virus; infectious mononucleosis; fulminant hepatitis;

D O I：

10.1016/j.medmal.2006.03.002

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

We report a case of fulminant hepatitis related to a primary Epstein-Barr virus (EBV) infection in an immunocompetent 15-year-old male patient. The main causes of fulminant hepatitis are viral infections, drugs, and autoimmune diseases. Primary Epstein-Barr virus infection is usually a benign, self-limited disease in pediatrics but can exceptionally be fatal. (C) 2006 Elsevier SAS. All rights reserved.

引用

页码：396 / 398

页数：3

共 10 条

[1] Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections [J].

Brengel-Pesce, K ;

Morand, P ;

Schmuck, A ;

Bourgeat, MJ ;

Buisson, M ;

Barguès, G ;

Bouzid, M ;

Seigneurin, JM .

JOURNAL OF MEDICAL VIROLOGY, 2002, 66 (03) :360-369

[2] Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene [J].

Coffey, AJ ;

Brooksbank, RA ;

Brandau, O ;

Oohashi, T ;

Howell, GR ;

Bye, JM ;

Cahn, AP ;

Durham, J ;

Heath, P ;

Wray, P ;

Pavitt, R ;

Wilkinson, J ;

Leversha, M ;

Huckle, E ;

Shaw-Smith, CJ ;

Dunham, A ;

Rhodes, S ;

Schuster, V ;

Porta, G ;

Yin, L ;

Serafini, P ;

Sylla, B ;

Zollo, M ;

Franco, B ;

Bolino, A ;

Seri, M ;

Lanyi, A ;

Davis, JR ;

Webster, D ;

Harris, A ;

Lenoir, G ;

St Basile, GD ;

Jones, A ;

Behloradsky, BH ;

Achatz, H ;

Murken, J ;

Fassler, R ;

Sumegi, J ;

Romeo, G ;

Vaudin, M ;

Ross, MT ;

Meindl, A ;

Bentley, DR .

NATURE GENETICS, 1998, 20 (02) :129-135

[3] Epstein-Barr virus infection. [J].

Cohen, JI .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (07) :481-492

[4] Fulminant Epstein-Barr viral hepatitis: Orthotopic liver transplantation and review of the literature [J].

Feranchak, AP ;

Tyson, RW ;

Narkewicz, MR ;

Karrer, FM ;

Sokol, RJ .

LIVER TRANSPLANTATION AND SURGERY, 1998, 4 (06) :469-476

[5] HEPATITIS IN FATAL INFECTIOUS-MONONUCLEOSIS [J].

MARKIN, RS ;

LINDER, J ;

ZUERLEIN, K ;

MROCZEK, E ;

GRIERSON, HL ;

BRICHACEK, B ;

PURTILO, DT .

GASTROENTEROLOGY, 1987, 93 (06) :1210-1217

[6]

PAPATHEODORIDIS GV, 1995, J HEPATOL, V23, P348, DOI 10.1016/S0168-8278(95)80015-8

[7]

PAVESE P, 2001, MED MALADIES INFECT, V53, P4475

[8] EXPRESSION OF EPSTEIN-BARR VIRUS-ENCODED SMALL RNA (BY THE EBER-1 GENE) IN LIVER SPECIMENS FROM TRANSPLANT RECIPIENTS WITH POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE [J].

RANDHAWA, PS ;

JAFFE, R ;

DEMETRIS, AJ ;

NALESNIK, M ;

STARZL, TE ;

CHEN, YY ;

WEISS, LM .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (24) :1710-1714

[9]

STAHL JP, 2005, REANIMATION, V14, P245

[10] DETECTION AND QUANTIFICATION OF VIRUS-DNA IN PLASMA OF PATIENTS WITH EPSTEIN-BARR VIRUS-ASSOCIATED DISEASES [J].

YAMAMOTO, M ;

KIMURA, H ;

HIRONAKA, T ;

HIRAI, K ;

HASEGAWA, S ;

KUZUSHIMA, K ;

SHIBATA, M ;

MORISHIMA, T .

JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (07) :1765-1768

← 1 →